시장보고서
상품코드
1619111

심혈관 디바이스 시장 규모, 점유율, 성장 분석 : 제품별, 용도별, 최종사용자별, 지역별 - 산업 예측(2024-2031년)

Cardiovascular Devices Market Size, Share, Growth Analysis, By Product (Diagnostic & Monitoring Devices, Surgical Devices), By Application (Coronary Artery Disease, Cardiac Arrhythmia), By End User, By Region - Industry Forecast 2024-2031

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 157 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 심혈관 디바이스 시장 규모는 2022년에 449억 달러로 평가되며, 2023년 491억 달러에서 2031년에는 949억 달러로 성장하며, 예측 기간 중(2024-2031년) CAGR은 8.5%로 성장할 전망입니다.

세계의 심혈관계 기기 시장은 만성 심혈관계 질환의 유병률 증가에 힘입어 강력한 성장세를 보이고 있습니다. 하버드대 T.H. Chan School of Public Health의 연구에 따르면 인도 마하라슈트라 주에서 심장마비가 43% 증가했는데, 이는 관상동맥 스텐트 비용의 감소로 인한 것으로 추정됩니다. 관상동맥 우회술 등 심장 필수 의약품의 가격 하락은 특히 인도와 같은 신흥 경제국에서 시장 확대를 더욱 촉진하고 있습니다. 주요 성장 촉진요인으로는 급속한 기술 발전, 전 세계 심혈관 질환의 부담 증가, 덜 침습적인 치료법으로의 전환 등을 들 수 있습니다. 또한 심장 기기 제조의 기술 혁신으로 적응증 확대와 환자 관리 개선으로 인해 심장 박동기와 같은 기기가 전 세계에서 심장질환의 효과적인 진단과 치료에 중요한 역할을 하고 있음이 밝혀졌습니다.

목차

서론

  • 조사의 목적
  • 조사 범위
  • 정의

조사 방법

  • 정보 조달
  • 2차 데이터와 1차 데이터 방법
  • 시장 규모 예측
  • 시장의 전제조건과 제한

개요

  • 세계 시장 전망
  • 공급과 수요의 동향 분석
  • 부문별 기회 분석

시장 역학과 전망

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 촉진요인과 기회
    • 억제요인과 과제
  • Porter의 산업 분석과 영향
    • 경쟁 기업 간 경쟁 관계
    • 대체품의 위협
    • 바이어의 교섭력
    • 신규 진출업체의 위협
    • 공급 기업의 교섭력

주요 시장 인사이트

  • 주요 성공 요인
  • 경쟁의 정도
  • 주요 투자 기회
  • 시장 에코시스템
  • 기술의 진보
  • 규제 상황
  • 특허 분석
  • 밸류체인 분석
  • PESTEL 분석
  • 거시경제 지표
  • 시장의 매력 지수

심혈관 디바이스 시장 규모 : 제품별 및 CAGR(2024-2031년)

  • 시장 개요
  • 진단 및 감시 디바이스
    • 심전도
    • 이식형 심장 모니터
    • 홀터 모니터
    • 모바일 심장 텔레메트리
    • MRI
    • 심장혈관 초음파 검사
    • 2D
    • 3D/4D
    • 도플러
    • 심장 진단 카테터
    • PET 스캐너
  • 외과용 기기
    • 심장재동기 요법(CRT)
    • CRT 제세동기
    • CRT 페이스메이커
    • 이식형 제세동기(ICD)
    • 단실형ICD
    • 듀얼 챔버 ICD
    • 페이스메이커
    • 기존형 페이스메이커
    • 리드리스 페이스메이커
    • 관상동맥 스텐트
    • 카테터
    • 가이드와이어
    • 캐뉼라
    • 밸브
    • 폐쇄 기기

심혈관 디바이스 시장 규모 : 용도별 및 CAGR(2024-2031년)

  • 시장 개요
  • 관상동맥 질환(CAD)
  • 부정맥
  • 심부전
  • 기타

심혈관 디바이스 시장 규모 : 최종사용자별 및 CAGR(2024-2031년)

  • 시장 개요
  • 병원
  • 전문 클리닉
  • 기타

심혈관 디바이스 시장 규모 및 CAGR(2024-2031년)

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 스페인
    • 프랑스
    • 이탈리아
    • 기타 유럽 지역
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 기타 라틴아메리카 지역
  • 중동 및 아프리카
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카

경쟁 정보

  • 상위 5사의 비교
  • 주요 기업의 시장 포지셔닝(2023년)
  • 주요 시장 기업이 채택한 전략
  • 시장의 최근 동향
  • 기업의 시장 점유율 분석(2023년)
  • 주요 기업의 기업 개요
    • 회사 개요
    • 제품 포트폴리오 분석
    • 부문별 점유율 분석
    • 매출의 전년대비 비교(2021-2023년)

주요 기업 개요

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • Johnson & Johnson
  • Terumo Corporation
  • Edwards Lifesciences Corporation
  • Biotronik SE & Co. KG
  • LivaNova PLC
  • Getinge AB
  • Baxter International Inc.(Hill-Rom Holdings, Inc.)
  • Koninklijke Philips N.V.
  • Siemens Healthineers AG
  • GE Healthcare
  • Toshiba Corporation
  • Fujifilm Holdings Corporation
  • Hitachi, Ltd.
  • Nihon Kohden Corporation
  • Collateral Medical Pvt. Ltd.
  • Schiller AG
  • B. Braun Melsungen AG

결론과 권장사항

KSA 25.01.15

Global Cardiovascular Devices Market size was valued at USD 44.9 billion in 2022 and is poised to grow from USD 49.1 billion in 2023 to USD 94.9 billion by 2031, growing at a CAGR of 8.5% during the forecast period (2024-2031).

The global cardiovascular device market is experiencing robust growth, driven by the rising incidence of chronic cardiovascular diseases. A study from Harvard's T.H. Chan School of Public Health highlights a 43% surge in cardiac arrests in Maharashtra, India, attributed to the reduced costs of coronary stents. The decline in essential cardiac drug prices, notably coronary artery bypass therapy, is further propelling market expansion, particularly in emerging economies like India. Key growth drivers include rapid technological advancements, a rising global burden of cardiovascular conditions, and a shift towards less invasive treatment options. Additionally, innovation in cardiac device manufacturing has broadened indications and improved patient management, underscoring the vital role of devices like pacemakers in effectively diagnosing and treating heart diseases globally.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiovascular Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiovascular Devices Market Segmental Analysis

Global Cardiovascular Devices Market is segmented by product, application, end user and region. Based on product, the market is segmented into Diagnostic & Monitoring Devices (ECG, Implantable Cardiac Monitors, Holter Monitors, Mobile Cardiac Telemetry, MRI, Cardiovascular Ultrasound (2D, 3D/4D, Doppler), Cardiac Diagnostic Catheters, PET Scanner), Surgical Devices (Cardiac Resynchronization Therapy (CRT) (CRT-Defibrillator, CRT-Pacemaker), Implantable Cardioverter Defibrillators (ICDs) (Single Chamber ICDs, Dual Chamber ICDs), Pacemakers (Conventional Pacemakers, Leadless Pacemakers), Coronary Stents, Catheters, Guidewires, Cannula, Valves, Occlusion Devices). Based on application, the market is segmented into Coronary Artery Disease (CAD), Cardiac Arrhythmia, Heart Failure and Others. Based on end user, the market is segmented into Hospitals, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiovascular Devices Market

The Global Cardiovascular Devices market is significantly influenced by the escalating incidence of cardiovascular diseases (CVDs), which remain the foremost cause of mortality worldwide. The rising prevalence of sedentary lifestyles, unhealthy diets, and an aging demographic contributes to an increased risk of conditions like congestive heart failure, hypertension, and heart failure. As a result, there is a growing necessity for vital medical devices, including pacemakers, defibrillators, and stents, particularly in both developed and developing regions. Health systems are now focusing on preventive care and early disease detection, while hospitals and clinics adopt advanced technologies to enhance patient outcomes. Furthermore, government initiatives and nonprofit organizations are actively promoting awareness among high-risk populations, further driving the market's growth.

Restraints in the Global Cardiovascular Devices Market

One significant constraint faced by the global cardiovascular devices market is the high cost associated with advanced equipment. This challenge is particularly pronounced in developing regions where the affordability of advanced devices, such as implantable cardioverter defibrillators (ICDs) and sophisticated imaging technologies, proves to be a substantial hurdle. The hefty price tags attached to these devices can deter healthcare providers and patients alike, limiting their availability and accessibility. Furthermore, inadequate insurance coverage and reimbursement options in certain areas exacerbate this issue, leaving patients without access to potentially life-saving technologies, ultimately hindering the growth and adoption of cardiovascular interventions.

Market Trends of the Global Cardiovascular Devices Market

The Global Cardiovascular Devices market is experiencing a significant shift towards expanding home health solutions, driven by the increasing demand for self-management tools and remote patient monitoring technologies. Wearable ECG devices, blood pressure monitors, and other innovative remote monitoring solutions enable patients to capture real-time health data, empowering them to manage chronic conditions like heart failure more effectively from the comfort of their homes. This trend not only improves patient convenience and engagement but also reduces healthcare costs and enhances the focus on preventive care. As patients seek greater autonomy in managing their health, the market is poised for sustained growth and innovation.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Technological Advancement
  • Regulatory Landscape
  • Patent Analysis
  • Value Chain Analysis
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Market Attractiveness Index

Global Cardiovascular Devices Market Size by Product & CAGR (2024-2031)

  • Market Overview
  • Diagnostic & Monitoring Devices
    • ECG
    • Implantable Cardiac Monitors
    • Holter Monitors
    • Mobile Cardiac Telemetry
    • MRI
    • Cardiovascular Ultrasound
    • 2D
    • 3D/4D
    • Doppler
    • Cardiac Diagnostic Catheters
    • PET Scanner
  • Surgical Devices
    • Cardiac Resynchronization Therapy (CRT)
    • CRT-Defibrillator
    • CRT-Pacemaker
    • Implantable Cardioverter Defibrillators (ICDs)
    • Single Chamber ICDs
    • Dual Chamber ICDs
    • Pacemakers
    • Conventional Pacemakers
    • Leadless Pacemakers
    • Coronary Stents
    • Catheters
    • Guidewires
    • Cannula
    • Valves
    • Occlusion Devices

Global Cardiovascular Devices Market Size by Application & CAGR (2024-2031)

  • Market Overview
  • Coronary Artery Disease (CAD)
  • Cardiac Arrhythmia
  • Heart Failure
  • Others

Global Cardiovascular Devices Market Size by End User & CAGR (2024-2031)

  • Market Overview
  • Hospitals
  • Specialty Clinics
  • Others

Global Cardiovascular Devices Market Size & CAGR (2024-2031)

  • North America (Product, Application, End User)
    • US
    • Canada
  • Europe (Product, Application, End User)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific (Product, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America (Product, Application, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Abbott Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Edwards Lifesciences Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biotronik SE & Co. KG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LivaNova PLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Getinge AB
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baxter International Inc. (Hill-Rom Holdings, Inc.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Koninklijke Philips N.V.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GE Healthcare
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Toshiba Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fujifilm Holdings Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hitachi, Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nihon Kohden Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Collateral Medical Pvt. Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Schiller AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제